Febuxostat Teva 80 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

febuxostat teva 80 mg apvalkotās tabletes

teva b.v., netherlands - febuksostats - apvalkotā tablete - 80 mg

Febuxostat Teva 120 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

febuxostat teva 120 mg apvalkotās tabletes

teva b.v., netherlands - febuksostats - apvalkotā tablete - 120 mg

Jayempi Eiropas Savienība - latviešu - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azatioprīns - transplanta noraidīšana - imūnsupresanti - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Febuxostat Mylan Eiropas Savienība - latviešu - EMA (European Medicines Agency)

febuxostat mylan

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigut preparāti - febuxostat mylan indicēts profilaksi un ārstēšanu pieaugušiem pacientiem veikta ķīmijterapija haematologic malignancies starpproduktu ar augsta riska audzēju līzes sindroms (tls) hyperuricaemia. febuxostat mylan ir indicēts, lai ārstētu hronisku hyperuricaemia apstākļos, kad urate uzklāšanas jau ir noticis (tai skaitā vēsturē, vai klātbūtne, tophus un/vai podagras artrīta). febuxostat mylan ir norādīts pieaugušie.

Imuran 50 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

imuran 50 mg apvalkotās tabletes

aspen pharma trading ltd., ireland - azatioprīns - apvalkotā tablete - 50 mg

Atsimutin 25 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

atsimutin 25 mg apvalkotās tabletes

pharmaswiss ceska republika s.r.o., czech republic - azatioprīns - apvalkotās tabletes - 25 mg

Atsimutin 50 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

atsimutin 50 mg apvalkotās tabletes

bausch health ireland limited, ireland - azatioprīns - apvalkotā tablete - 50 mg

Zenapax Eiropas Savienība - latviešu - EMA (European Medicines Agency)

zenapax

roche registration ltd. - daclizumab - graft rejection; kidney transplantation - imūnsupresanti - zenapax ir indicēts orgānu akūtu atteikuma de novo allogenic nieru transplantācijas profilaksei un ir jālieto kopā ar imunitāti nomācošu režīms, ieskaitot cyclosporine un kortikosteroīdi pacientiem, kuriem nav imunizēti augsti.

NeuroMax forte apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

neuromax forte apvalkotās tabletes

vitabalans oy, finland - thiamini hydrochloridum, cyanocobalaminum, pyridoxini hydrochloridum - apvalkotā tablete

Pentasa 1 g ilgstošās darbības granulas Latvija - latviešu - Zāļu valsts aģentūra

pentasa 1 g ilgstošās darbības granulas

ferring gmbh, germany - mesalazīns - ilgstošās darbības granulas - 1 g